# Lifecore Biomedical (LFCR) — Earnings

LFCR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/lfcr/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.19 |
| EPS estimate | −$0.29 |
| EPS surprise | +34.48% |
| Revenue surprise | +3.13% |
| Revenue | $34.2M |
| Revenue estimate | $33.1M |
| Reported | Aug 5, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1005286/000100528626000033/lfcr-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/a9483222-ac24-d70c-8f71-64bfdf1ba91b.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 5, 2026 | −$0.29 | −$0.19 | 34.48% | $33.1M | $34.2M |
| Q1 2026 | May 6, 2026 | −$0.29 | −$0.43 | -48.28% | $26.0M | $23.2M |
| Q4 2025 | Mar 16, 2026 | −$0.29 | −$0.16 | 44.83% | $33.1M | $35.7M |
| Q2 2025 | Jan 2, 2025 | −$0.29 | −$0.16 | 44.83% | $33.1M | $35.7M |
| Q4 2023 | Aug 31, 2023 | −$0.12 | −$0.16 | -33.33% | $35.0M | $37.9M |
| Q3 2023 | Jun 1, 2023 | −$0.06 | $0.40 | 766.67% | $35.8M | $35.7M |
| Q2 2023 | Mar 16, 2023 | −$0.21 | $0.39 | 285.71% | $30.2M | $30.1M |
| Q1 2023 | Oct 6, 2022 | −$0.39 | −$0.35 | 10.26% | $24.5M | $24.5M |
| Q4 2022 | Aug 10, 2022 | −$0.45 | −$1.19 | -167.42% | $29.0M | $31.5M |
| Q3 2022 | Apr 5, 2022 | −$0.18 | −$1.33 | -638.89% | $28.0M | $27.6M |
| Q2 2022 | Jan 5, 2022 | −$0.21 | −$0.42 | -100.00% | $43.0M | $38.8M |
| Q1 2022 | Sep 29, 2021 | −$0.18 | −$0.41 | -134.29% | $42.7M | $43.4M |
| Q4 2021 | Jul 28, 2021 | −$0.03 | −$1.24 | -4409.09% | $45.9M | $47.6M |
| Q3 2021 | Apr 7, 2021 | $0.01 | −$0.43 | -4400.00% | $48.4M | $53.1M |
| Q2 2021 | Jan 6, 2021 | −$0.08 | −$1.30 | -1577.42% | $131.7M | $129.5M |
| Q1 2021 | Oct 6, 2020 | −$0.15 | −$0.32 | -116.22% | $129.1M | $128.8M |
| Q4 2020 | Aug 11, 2020 | −$0.02 | −$0.10 | -525.00% | $124.6M | $139.8M |
| Q3 2020 | Mar 31, 2020 | $0.02 | −$0.19 | -975.58% | $135.5M | $137.8M |
| Q2 2020 | Jan 2, 2020 | $0.01 | −$0.45 | -5521.69% | $134.4M | $130.9M |
| Q1 2020 | Oct 1, 2019 | −$0.13 | −$0.38 | -188.53% | $127.4M | $135.6M |

## Frequently Asked Questions

### When did Lifecore Biomedical (LFCR) last report earnings?

Lifecore Biomedical last reported on Aug 5, 2026, covering fiscal Q2 2026.

### Did LFCR beat earnings estimates?

Yes. Lifecore Biomedical reported EPS of −$0.19 for Q2 2026 against a −$0.29 estimate — a 34.48% beat.

### How much revenue did LFCR report last quarter?

Lifecore Biomedical reported $34.2M in revenue for Q2 2026, against a consensus estimate of $33.1M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).